Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

1.06
+0.02502.43%
Pre-market: 1.05-0.0048-0.45%09:04 EDT
Volume:1.92M
Turnover:2.00M
Market Cap:130.82M
PE:-1.56
High:1.07
Open:1.07
Low:1.03
Close:1.03
52wk High:3.06
52wk Low:1.00
Shares:124.00M
Float Shares:106.47M
Volume Ratio:0.98
T/O Rate:1.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6748
EPS(LYR):-0.7517
ROE:-35522.62%
ROA:-42.78%
PB:7.18
PE(LYR):-1.40

Loading ...

Avalyn Pharma completes target enrollment in MIST trial

TIPRANKS
·
Jun 17

Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis

GlobeNewswire
·
Jun 17

Milestone Pharmaceuticals shareholders approve 6.8 million-share increase to 2019 equity plan

Reuters
·
Jun 16

Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)

TIPRANKS
·
May 27

Milestone Pharmaceuticals (MIST) Gets a Buy from Piper Sandler

TIPRANKS
·
May 14

Milestone Pharmaceuticals files $300M mixed securities shelf

TIPRANKS
·
May 14

Milestone Pharmaceuticals Files $300 Million Mixed Shelf

MT Newswires Live
·
May 14

BRIEF-Milestone Pharmaceuticals Inc - May Offer Securities Up To $300 Million - SEC Filing

Reuters
·
May 14

Milestone Pharmaceuticals Inc - May Offer up to $100 Mln Common Shares via Cantor Fitzgerald Sales Agreement - SEC Filing

THOMSON REUTERS
·
May 14

Analyst Reiterates Buy on MIST, Maintains $8 Price Target on Strong CARDAMYST Launch and Expanded AFib Opportunity

TIPRANKS
·
May 14

Milestone Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Milestone Shares Fall on Unexpected 1Q Loss

Dow Jones
·
May 13

Canada's Milestone Pharmaceuticals Q1 revenue misses estimates after CARDAMYST launch

Reuters
·
May 13

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 13

Milestone Pharmaceuticals Q1 Revenue USD 238 Thousand VS. Ibes Estimate USD 37.6 Million

THOMSON REUTERS
·
May 13

Milestone Pharma Q1 net loss widens 25.6% to $26.07 million

Reuters
·
May 13

Milestone Pharmaceuticals Q1 EPS $(0.20) Misses $0.14 Estimate, Sales $238.000K

Benzinga Earnings
·
May 13

Milestone Pharmaceuticals Inc expected to post earnings of 31 cents a share - Earnings Preview

Reuters
·
May 11

Milestone Pharmaceuticals to report Q1 2026 results, host investor call

Reuters
·
May 06

Milestone Pharmaceuticals announces annual shareholder meeting

Reuters
·
May 01